SCHEMBL4454083

SCHEMBL4454083

CCc1nocc1-c1ccccc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 6/20 0.39
SENP8 Q96LD8 6/20 0.39
SENP7 Q9BQF6 6/20 0.39
SENP6 Q9GZR1 6/20 0.39
MAPK1 P28482 1/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
HPGD P15428 5/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
RAB9A P51151 4/20 0.36
NPC1 O15118 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
NFKB1 P19838 2/20 0.36
CYP2C19 P33261 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27801909 0.77 PTGS2 (0.44) MAPK1LMNARAB9ANPC1SMN1; SMN2
SCHEMBL18240475 0.73
SCHEMBL27685077 0.70 SMN1; SMN2 (0.43) CASP3SENP8SENP7SENP6LMNA
Alcohol SCHEMBL20553646 0.70 ALDH1A1 (0.59) MAPK1LMNATSHRHPGDRAB9A
SCHEMBL980892 0.67 GABRA1 (0.50) LMNATSHRHPGDCYP2D6ALDH1A1
SCHEMBL29362539 0.67 GABRA1 (0.50) LMNATSHRHPGDCYP2D6ALDH1A1
SCHEMBL28574 0.67 ALDH1A1 (0.67) CASP3SENP8SENP7SENP6LMNA
SCHEMBL30442890 0.67 ALDH1A1 (0.67) CASP3SENP8SENP7SENP6LMNA
SCHEMBL29623192 0.67 ALDH1A1 (0.67) CASP3SENP8SENP7SENP6LMNA
SCHEMBL27659427 0.67 ALDH1A1 (0.67) CASP3SENP8SENP7SENP6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GILLESPIE PAUL 2009-06-18 US disclosed
US-7524870-B2 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators HOFFMANN-LA ROCHE INC. (US) 2009-04-28 US disclosed
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GILLESPIE PAUL 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GYS2, GYS1, GSK3A CASP3 2344/4885SENP8 4520/4885SENP7 4417/4885
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GYS2, GYS1, GSK3A CASP3 2344/4885SENP8 4520/4885SENP7 4417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.